Premium
Private equity firm India Alternatives has picked up a significant minority stake in a dermatology-focused healthcare company for about $8 million (Rs 55.6 crore). The PE firm has bought the stake in Brinton Pharmaceuticals Ltd, which is focused on dermatology but has recently expanded into the paediatric dermatology and respiratory segments. “The ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
